lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

Similar documents
(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

Best practices of ASRM and ESHRE

AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD

Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation

Prognosticating ovarian reserve by the new ovarian response prediction index

JMSCR Vol 06 Issue 09 Page September 2018

LOW RESPONDERS. Poor Ovarian Response, Por

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest

The emergence of Personalized Medicine protocols for IVF.

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis

LH activity administration during the

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve

Questions. Ultrasound markers of ovarian reserve Modena April 18-19, Your choice is.. Impact study: stop OR tests or Soft catheters??

A Tale of Three Hormones: hcg, Progesterone and AMH

Poor & Hyper responders: what is the best approach?

Personalizing ovarian stimulation for IVF

S. AMH in PCOS Research Insights beyond a Diagnostic Marker

(BMI)=18.0~24.9 kg/m 2 ;

Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Infertility Clinical Guideline

ENDOCRINE CHARACTERISTICS OF ART CYCLES

Results and Discussion

Principles of Ovarian Stimulation

University of Groningen. Female reproductive ageing Haadsma, Maaike Laura

Individualized treatment based on ovarian reserve markers

EVALUATING THREE ALTERNATIVE PROTOCOLS FOR IMPROVING OVARIAN RESPOSE OF THE POOR RESPONDERS UNDERGOING ASSISSTED REPRODUCTIVE TECHNIQUES

NGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam

Neil Goodman, MD, FACE

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.

MODULE 1: OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS

Article Evaluation of functional ovarian reserve in 60 patients

Treatment of Poor Responders

Reproduction. AMH Anti-Müllerian Hormone. Analyte Information

Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients

Summary

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy

Thesis. Mahmoud Sedki Yassin (MsC) Cairo University. Under supervision of

Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

Individualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization

STIMULATION AND OVULATION TRIGGERING

Research Article. Jayakrishnan Krishnakumar 1, Akansha Agarwal 1, Divya Nambiar 1, Shankar Radhakrishnan 2 *

INFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients

Association of ovarian reserve with age, BMI and serum FSH level in subfertile women

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome

Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve

Medicine, Al-Nahrain University

Utility of Estradiol as a Predictive Marker of Ovarian Hyper Stimulation Syndrome

A Tale of Three Hormones: hcg, Progesterone and AMH

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Antral follicle count as a predictor of ovarian response

Age specific serum anti-müllerian hormone levels in 1,298 Korean women with regular menstruation

Infertility: A Generalist s Perspective

The intra-follicular molecular biology mandating advancement of egg retrieval in some women

Lan Wang, Yiqing Zhao, Xiyuan Dong, Kai Huang, Rui Wang, Licheng Ji, Ya Wang, Hanwang Zhang

Potentials for iatrogenic ovarian hyporresponse following

2017 United HealthCare Services, Inc.

Endocrinology of the Female Reproductive Axis

Aims of this talk. Evaluation & investigation. Basic treatments/options including ovulation induction & Intra uterine Insemination

Low AMH and natural conception. Dr. Phil Boyle Galway, Ireland IIRRM Annual Meeting, 7 th August 2013

Reproductive FSH. Analyte Information

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Liyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

The Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization

Evaluation of basal estradiol levels in assisted reproductive technology cycles

IN VITRO FERTILIZATION

Elena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a

Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?

Understanding Infertility, Evaluations, and Treatment Options

Evidence-based treatment of POR and POF. Ovarian Club X and CoGEN in Asia December 16-17, 2017 Hong Kong

International Journal of Pharma and Bio Sciences ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN ABSTRACT

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group

WHY INVESTIGATE FOR INFERTILITY

Laboratoires Genevirer Menotrophin IU 1.8.2

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

Inhibin B and anti-mullerian hormone: markers of ovarian response in IVF/ICSI patients?

Raoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest

in vitro fertilization

Changes in measured endometrial thickness predict in vitro fertilization success

Ovarian hyperstimulation syndrome (OHSS)

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

Predictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles

Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome

Article Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?

Assessment of ovarian reserve: Anti Mullerian hormone versus follicle stimulating hormone

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

Transcription:

lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012

Why good prediction of poor response good prediction i of OHSS application appropriate stimulation protocols good prediction of successful pregnancy

Cilinical Prediction Markers of Ovarian Response and Pregnancy Prediction of no response Age Menstrual cycle length (MCL) Previous no or low response Prediction of high response Age BMI PCO Previous high response

Female Age is very important in consideration of probability for conception because it is very much related to egg quality. A 45 year old can have good quality eggs (for her age) and still be fertile, although this is quite uncommon. At the other extreme, a 25 year old can have very poor quality eggs and be infertile unless she uses donor eggs. These are extreme examples, but the point is that egg quantity and quality tends to decline significantly in the 30s and faster in the early 40s, but egg quantity and quality in an individual woman can be average for her age, better than average, or worse than average.

Menstrual Pattern Menstrual cycle length (MCL) a gradual shortening in cycle length may initiate in the late 30s, in parallel with higher serum (FSH) and lower serum levels of inhibins correlation between MCL and the antral follicle count (AFC) during ultrasonographic evaluation MCL had significant association with ovarian response to gonadotropinstimulus ti and embryoquality in IVF/ICSIcycles even if the interference of age is excluded, pregnancy rates are almost twice as high among womenwithcycles>34 days when compared with those with cycles<26 days

Lab Prediction Markers of Ovarian Response and Prgnancy Lab tests before starting COH Lab tests after starting 1. To determine ovarian reserve COH STATIC tests 1. To determine ovarian 3 day FSH,Estradiol,AMH, response 5 day Inhibin B Inhibin B 5 day AMH AFC,ovarian vol,ovarianovarian flow Estradiol DYNAMIC tests CCCT,EFFORT,GAST,AMH,, 5 2. To determine OHSS 2. To determine ovarian suppression Estradiol E2, Progestrone, US

Endocrine Static ti Tests ORTs

Estimated ROC curve and sensitivity specificity points for all studies reporting on the performance of basal FSH in the prediction of poor response. Broekmans F et al. Hum. Reprod. Update 2006;12:685-718 The Author 2niversity Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org006. Published by Oxford U

Estimated ROC curve and sensitivity specificity points for all studies reporting on the performance of basal FSH in the prediction of non-pregnancy. Broekmans F et al. Hum. Reprod. Update 2006;12:685-718 The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Broekmans FJ systematic review of tests predicting ovarian reserve andivfoutcome outcome. Human Reproduction Update. 2006 Accuracy in the prediction of poor response and nonpregnancy is adequate only at very high threshold levels, but because of the very low numbers of abnormal tests has hardly any clinical value. Thetestwillnotbesuitableasadiagnostictestto exclude patients, but only as screening test for counselling purposes

de Carvalho et al Ovarian Reserve Assessment for Infertility Investigation ISRN Obstet Gynecol. 2012 FSH continues to be an interesting ti testt on ovarian reserve investigation, since it is an easily accessible and low cost marker could be useful in pretreatment evaluation of specific groups of infertile women with anovulatory cycles, endometriosis or in patients over 35years of age. high FSH levels should not be used to exclude women from proceeding with ART

AMH a glycoprotein hormone of the TGF β superfamily expressed by granulosa cells as soon as the primordial follicles l are recruited The biological activity of AMH in women is not completely understood, but data along the last years suggest thatt it may act as a modulator of follicle l recruitment and a regulator of ovarian steroidogenesis

AMH AMH is considered to be a marker that can estimate the quantity and activity of retrievable follicles in early stages of maturation, thus being more reliable for the prediction of ovarianresponseresponse and reproductive e potential Compared to FSH, inhibin B, and E2, AMH has the advantage of reduced variability of its serum concentrations along the menstrual cycle

AMH

Estimated ROC curve and sensitivity specificity points for all studies reporting on the performance of AMH in the prediction of non-pregnancy. Broekmans F et al. Hum. Reprod. Update 2006;12:685-718 The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Broekmans FJ systematic review of tests predictingovarian reserve and IVF outcome. Human Reproduction Update. 2006 sensitivity of 75% and specificity of 85% would imply that test performs only moderately For non pregnancy prediction, sensitivity of 40% and specificity of 95% would imply that the test has hardly any value, unless very low threshold levels would be used, which will certainly lead to only very small percentages of abnormal tests. Additional studies

Anti Mullerian hormone as a predictive marker in ART. Hum Rep Update 2010 AMH better marker than age, FSH, estradiol and inhibin B. similar performance for AMH andafc In clinical practice, AMH measurement may be useful in the prediction of poor response and alsoof hyper response

Circulating basal anti Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.fertility Sterility 2009 Circulating AMH has the ability to predict excessive and poor response to stimulation with exogenous gonadotrophins. Overall, this biomarker is superior to basal FSH and AFC

A prospective, comparative analysis of anti Müllerian hormone, inhibin B, and three dimensional ultrasound determinants of ovarian reserve in the prediction i of poor response to controlled ovarian stimulation. Fertility and Sterility 2010 The AFC and AMH are the most significant predictors of poor response but are not predictive of non conception, which is dependent on the woman's age.

AMH The lack of a consensual cutoff combining satisfactory sensitivity and specificity considerable drawback levels<1ng/ml poor response levels from 1 to 4ng/mL normal response levels>4ng/ml high response

Inhibin B glycoproteinhormones ofthe (TGF β) secreted by granulosa and theca cells. Inhibin B inhibits pituitary FSH secretion and paracrine action on developing follicles

Seifer DB Day 3 serum inhibin B is predictive of assisted itdreproductive technologies outcome. Fertility and Sterility 1997 demonstrated diminished basal serum concentrations of inhibin B, in spite of non elevated dday 3 FSH levels. l In poor responders inhibin B levels 45pg/mL greater estrogen responses and higher amounts of oocytes lower levelsl cancellations were three times more

Peñarrubia J Day 5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression. Fertility and Sterility 2010 day 5 inhibin B was associated with live birth rates after IVF with 68.71% sensitivity and 88.51% specificity, which was statistically significant and stronger than any other variable investigated

Broekmans FJ systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update. 2006 high rate of false positives in routine determination of basal inhibin B and cautiously exclusion of patients from IVF programs with base on its levels. even using very low inhibin B levels, accuracy of the test in predicting poor response was only modest when compared with the other available markers, even though it can be used as a tool for counseling infertile couples

Estradiol rising FSH levels in older women advanced follicular development and early selection of a dominant follicle early elevations in serum E2 Measurement of both FSH and E2 on cycle day 3 help to diminish the incidence of false negative tests based on measurement of FSH alone when both markers are precociously elevated, poor ovarian response is likely to occur

Estradiol E2 may be used to guide the clinician as to whether the stimulation with gonadotropins can be started, Considering the low predictive accuracy and the lack of high sensitivity and specificity cutoff levels,itsroleasa determinant for couples inclusion in ART programs should be evaded

Endocrine Dynamic Tests

CCCT 100mg clomiphene citrate was administered to women aged 35yearsfromdays5 9of the menstrual cycle. FSH, LH, and E2 levels were primarily determined on cycle days 2 3, and response was determined on cycle days 9 11. Diminished ovarian reserve was determined by day 3 FSH >14.9mIU/mL or day 10 FSH> day 3 FSH

CCCT values of likelihood ratios of positive and negative CCCT did not provide sufficient evidence for prediction of non pregnancy or ART cycle cancellation in 20 eligible studies. the absence of standardized abnormal test definitions prevented strong conclusions and authors could not support its use as a prognostic tool

Gonadotropin Analogue Stimulation Test (GAST) measurement of FSH, LH, inhibin B B, and E2 levels flare up within 24 hours of administration of gonadotropin analogue wide variety of (GnRH) analogue doses and administration timing, hormones tested in initial and final samples, and their thresholds were not standardized.just like the CCCT, GAST should not be an eligible ovarian reserve test in clinical routine, with the present bodyof evidence.

Exogenous FSH Ovarian Reserve Test (EFORT) is based on the increase of E2 and inhibin B 24 hours after the administration of 300IU of (rfsh) on cycle day 3 as with CCCT and GAST, methodology for EFORT is far from uniform parameters should be avoided in determining ovarian reserve for infertile patients.

Thank you for your attention